Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)

NCT00651482 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Kidney Neoplasms
Kidney (Renal Cell) Cancer

Interventions

DRUG: Everolimus
DRUG: Bevacizumab

Sponsor

Sandy Srinivas

Collaborators

[object Object]
[object Object]